$80,000 of CLEANSPARK INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Banking reform as it relates to digital assets Financial inclusion as it relates to digital assets Tax reform tariff issues related to imported goods Issues related to importing goods"
You can find more data on corporate lobbying on Quiver Quantitative.
CLSK Insider Trading Activity
CLSK insiders have traded $CLSK stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CLSK stock by insiders over the last 6 months:
- THOMAS LEIGH WOOD sold 85,315 shares for an estimated $997,110
- TAYLOR MONNIG (CTO, COO) sold 63,713 shares for an estimated $581,062
- AMANDA CAVALERI sold 33,000 shares for an estimated $495,660
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLSK Hedge Fund Activity
We have seen 189 institutional investors add shares of CLSK stock to their portfolio, and 172 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 4,183,354 shares (-39.8%) from their portfolio in Q3 2025, for an estimated $60,658,633
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 3,865,946 shares (+inf%) to their portfolio in Q3 2025, for an estimated $56,056,217
- D. E. SHAW & CO., INC. added 3,559,228 shares (+inf%) to their portfolio in Q3 2025, for an estimated $51,608,806
- BERYL CAPITAL MANAGEMENT LLC added 2,023,507 shares (+inf%) to their portfolio in Q3 2025, for an estimated $29,340,851
- POINT72 ASSET MANAGEMENT, L.P. added 1,955,212 shares (+inf%) to their portfolio in Q3 2025, for an estimated $28,350,574
- DIMENSIONAL FUND ADVISORS LP added 1,564,761 shares (+57.0%) to their portfolio in Q3 2025, for an estimated $22,689,034
- TUDOR INVESTMENT CORP ET AL added 1,424,439 shares (+462.7%) to their portfolio in Q3 2025, for an estimated $20,654,365
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CLSK Analyst Ratings
Wall Street analysts have issued reports on $CLSK in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 11/26/2025
- Needham issued a "Buy" rating on 11/26/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/26/2025
- Chardan Capital issued a "Buy" rating on 11/26/2025
- Macquarie issued a "Outperform" rating on 11/26/2025
- JP Morgan issued a "Overweight" rating on 11/24/2025
- Bernstein issued a "Outperform" rating on 11/03/2025
To track analyst ratings and price targets for CLSK, check out Quiver Quantitative's $CLSK forecast page.
CLSK Price Targets
Multiple analysts have issued price targets for $CLSK recently. We have seen 10 analysts offer price targets for $CLSK in the last 6 months, with a median target of $24.5.
Here are some recent targets:
- John Todaro from Needham set a target price of $25.0 on 11/26/2025
- Mike Colonnese from HC Wainwright & Co. set a target price of $27.0 on 11/26/2025
- Paul Golding from Macquarie set a target price of $27.0 on 11/26/2025
- Nick Giles from B. Riley Securities set a target price of $22.0 on 11/26/2025
- James McIlree from Chardan Capital set a target price of $30.0 on 11/26/2025
- Reginald Smith from JP Morgan set a target price of $14.0 on 11/24/2025
- Brett Knoblauch from Cantor Fitzgerald set a target price of $23.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
